Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of valescent plasma to the standard of care in patients hospitalized with COVID- nCoV (DAWn-Plasma) trial.
Devos, Timothy
Devos, Timothy
Citations
Altmetric:
Abstract
Description
Date
2020-12-14
Journal Title
Journal ISSN
Volume Title
Publisher
Chapter title
Publication type
Peer reviewed scientific article